FDA, Hims and Trump
Nano Nuclear Energy, Cassava Sciences, and Hims & Hers
The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...
On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $25.33 which represents a slight increase of $1.18 or 4.89% from the prior close of $24.15. The stock opened at ...
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...
Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...
Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has received a consensus rating of “Hold” from the sixteen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback